External Validation of the MSKCC and IMDC Risk Models in Patients Treated with Targeted Therapy as a First-line and Subsequent Second-line Treatment: A Japanese Multi-institutional Study

Autor: Tanaka, Nobuyuki, Mizuno, Ryuichi, Ito, Keiichi, Shirotake, Suguru, Yasumizu, Yota, Masunaga, Ayako, Ito, Yujiro, Miyazaki, Yasumasa, Hagiwara, Masayuki, Kanao, Kent, Mikami, Shuji, Nakagawa, Ken, Momma, Tetsuo, Masuda, Takeshi, Asano, Tomohiko, Oyama, Masafumi, Oya, Mototsugu
Zdroj: In European Urology Focus August 2016 2(3):303-309
Databáze: ScienceDirect